Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buprenorphine 5micrograms/hour transdermal patches
0407020B0AAAHAH
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 60,643 |
|
Buprenorphine 10micrograms/hour transdermal patches
0407020B0AAAIAI
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 48,326 |
|
Buprenorphine 20micrograms/hour transdermal patches
0407020B0AAAJAJ
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 19,382 |
|
Buprenorphine 15micrograms/hour transdermal patches
0407020B0AAAKAK
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 16,239 |
|
Buprenorphine 400microgram sublingual tablets sugar free
0407020B0AAADAD
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 10,615 |
|
Buprenorphine 200microgram sublingual tablets sugar free
0407020B0AAABAB
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 10,339 |
|
Buprenorphine 35micrograms/hour transdermal patches
0407020B0AAAEAE
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 6,602 |
|
Buprenorphine 52.5micrograms/hour transdermal patches
0407020B0AAAFAF
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 3,127 |
|
Buprenorphine 70micrograms/hour transdermal patches
0407020B0AAAGAG
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 1,927 |
|
Buprenorphine 25micrograms/hour transdermal patches
0407020B0AAALAL
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 416 |
|
Buprenorphine 30micrograms/hour transdermal patches
0407020B0AAAMAM
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 270 |
|
Buprenorphine 40micrograms/hour transdermal patches
0407020B0AAANAN
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 91 |
|
Buprenorphine 300micrograms/1ml inj ampoules
0407020B0AAAAAA
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.